Peripheral Purinergic Receptor Modulation Influences the Trigeminal Ganglia Nitroxidergic System in an Experimental Murine Model of Inflammatory Orofacial Pain

被引：17

作者：

Borsani, Elisa ^{[1
]}

Albertini, Roberta ^{[1
]}

Labanca, Mauro ^{[1
,2
]}

Lonati, Claudio ^{[1
]}

Rezzani, Rita ^{[1
]}

Rodella, Luigi F. ^{[1
]}

机构：

[1] Univ Brescia, Div Human Anat, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy

[2] Univ Vita Salute San Raffaele, Dept Dent, Milan, Italy

来源：

JOURNAL OF NEUROSCIENCE RESEARCH | 2010年 / 88卷 / 12期

关键词：

purinergic receptors; trigeminal system; nitroxidergic system; inflammatory pain; mice; NITRIC-OXIDE SYNTHASE; 1-(2-TRIFLUOROMETHYLPHENYL) IMIDAZOLE TRIM; FOS-LIKE IMMUNOREACTIVITY; CYCLIC-GMP PATHWAY; C-FOS; NOCICEPTIVE RESPONSES; NUCLEUS CAUDALIS; SENSORY COMPLEX; ZIF/268; EXPRESSION; EXTRACELLULAR ATP;

D O I：

10.1002/jnr.22420

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

ATP plays an important role as an endogenous pain mediator generating and/or modulating pain signaling from the periphery to the central nervous system. The aim of this study was to analyze the role of peripheral purinergic receptors in modulation of the nitroxidergic system at a trigeminal ganglia level by monitoring changes in nitric oxide synthase isoforms. We also evaluated Fos-positive neurons in brainstem (spinal trigeminal nucleus) and pain-related behavior. We found that local administration of the P2 purinergic receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) decreased face-rubbing activity, nitric oxide synthase isoform expression in trigeminal ganglia, and Fos expression in spinal trigeminal nucleus after subcutaneous injection of formalin. These results suggest a role for peripheral P2 purinergic receptors in orofacial pain transmission through modulation of the nitroxidergic system. (C) 2010 Wiley-Liss, Inc.

引用

页码：2715 / 2726

页数：12

共 61 条

[11]

Franklin K. B. J., 2013, MOUSE BRAIN STEREOTA

[12] EXTRACELLULAR ATP - EFFECTS, SOURCES AND FATE [J].

GORDON, JL .

BIOCHEMICAL JOURNAL, 1986, 233 (02) :309-319

[13] P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats [J].

Gourine, AV ;

Poputnikov, DM ;

Zhernosek, N ;

Melenchuk, EV ;

Gerstberger, R ;

Spyer, KM ;

Gourine, VN .

BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (01) :139-145

[14] Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice [J].

Guan, Yun ;

Yaster, Myron ;

Raja, Srinivasa N. ;

Tao, Yuan-Xiang .

MOLECULAR PAIN, 2007, 3

[15] The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques [J].

Haga, KK ;

Gregory, LJ ;

Hicks, CA ;

Ward, MA ;

Beech, JS ;

Bath, PW ;

Williams, SCR ;

O'Neill, MJ .

BRAIN RESEARCH, 2003, 993 (1-2) :42-53

[16] ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia [J].

Hamilton, SG ;

Warburton, J ;

Bhattacharjee, A ;

Ward, J ;

McMahon, SB .

BRAIN, 2000, 123 :1238-1246

[17] THE ANTINOCICEPTIVE EFFECT OF 1-(2-TRIFLUOROMETHYLPHENYL) IMIDAZOLE (TRIM), A POTENT INHIBITOR OF NEURONAL NITRIC-OXIDE SYNTHASE IN-VITRO, IN THE MOUSE [J].

HANDY, RLC ;

WALLACE, HP ;

GAFFEN, ZA ;

WHITEHEAD, KJ ;

MOORE, PK .

BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) :2349-2350

[18] Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects [J].

Handy, RLC ;

Harb, HL ;

Wallace, P ;

Gaffen, Z ;

Whitehead, KJ ;

Moore, PK .

BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (02) :423-431

[19] The effect of neonatal capsaicin on the c-Fos-like immunoreactivity induced in subnucleus oralis neurons by noxious intraoral stimulation [J].

He, YF ;

Ichikawa, H ;

Sugimoto, T .

BRAIN RESEARCH, 2000, 860 (1-2) :203-207

[20] The function of microglia through purinergic receptors: Neuropathic pain and cytokine release [J].

Inoue, K .

PHARMACOLOGY & THERAPEUTICS, 2006, 109 (1-2) :210-226

← 1 2 3 4 5 6 7 →